IDIBAPS publishes more than 300 scientific articles on the disease every year, which represent 22.5% of the total number of publications of the ins...
On 11 February, International Day of Women and Girls in Science, a new edition of the #100tífiques (100 female scientists) talks will be held, both...
This analysis, the largest conducted to date and led by Hospital Clínic–IDIBAPS researchers, provides evidence of the inefficacy of this therapeuti...
Researchers from the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) and the IIBB-CSIC-IDIBAPS have led the study, published in...
The finding may make it possible to take therapeutic approaches that will increase the success rate of cognitive-behavioral therapy. This is the th...
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
Researchers at Hospital Clínic-IDIBAPS are leading the CIBERESUCICOVID project, which seeks to identify the risk and prognosis factors of patients...
Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in...
The study shows how the average life of the virus is drastically reduced, in transplanted patients and cell cultures alike.
The inhibition of this molecule, in addition to reducing the predisposition towards developing the disease, also reduces the alteration of the micr...
